Reposted by Klaus Schmierer
Professor Klaus Schmierer @klausschmierer.bsky.social on the possibility of "precision medicine" and using immune cell phenotyping to optimally dose-b cell depleters (ocrevus/kesimpta/briumvi/rituximab) for multiple sclerosis. onlinelibrary.wiley.com/doi/10.1111/...